Heron Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
17:25 ET
Heron Therapeutics | 8-K: Current report
Mar 21 16:38 ET
Heron Therapeutics | 8-K: Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
Mar 12 16:15 ET
Heron Therapeutics | 8-K: Current report
Jan 24 08:04 ET
Heron Therapeutics | 8-K: Current report
Jan 11 00:00 ET
Heron Therapeutics | 8-K: Current report
Dec 22, 2023 16:30 ET
Heron Therapeutics | 8-K: Current report
Dec 21, 2023 17:25 ET
Heron Therapeutics | 8-K: Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
Nov 14, 2023 16:10 ET
Heron Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aug 23, 2023 16:08 ET
Heron Therapeutics | 8-K: Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
Aug 14, 2023 16:11 ET
Heron Therapeutics | 8-K: Current report
Jul 24, 2023 09:12 ET
Heron Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jun 30, 2023 16:06 ET
Heron Therapeutics | 8-K: Current report
Jun 23, 2023 16:19 ET
Heron Therapeutics | 8-K: Current report
Jun 12, 2023 09:10 ET
Heron Therapeutics | 8-K: Current report
May 11, 2023 16:06 ET
Heron Therapeutics | DEF 14A: Definitive proxy statements
May 1, 2023 09:00 ET
Heron Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Apr 20, 2023 16:06 ET
Heron Therapeutics | 8-K: Current report
Apr 20, 2023 09:10 ET
Heron Therapeutics | 8-K: Current report
Apr 3, 2023 09:10 ET
Heron Therapeutics | 8-K: Current report
Mar 23, 2023 16:10 ET
No Data
No Data